Weight-loss Drug Response Varies, But Why? - Takeaways - MDSpire
Clinical Guidelines
Feature

Weight-loss Drug Response Varies, But Why?

Study links DNA variants to weight loss and side effects

  • May 5, 2026

  • 2 min

Share

  • 1

    Study analyzed genetic factors affecting GLP-1 drug response.

  • 2

    Data included nearly 28,000 participants.

  • 3

    Variants in GLP1 receptor gene linked to an average weight loss of 0.76 kg.

  • 4

    Findings suggest genetics influence treatment effectiveness and side effects.

  • 5

    Side effects observed included nausea and vomiting.

  • 6

    Research supports personalized treatment strategies in weight management.

  • 7

    Combination of genetic and clinical data can improve prediction of treatment outcomes.

Original Source(s)

Weight-loss Drug Response Varies, But Why?

  • May 5, 2026

Related Content

This Week’s CGT News: CRISPR Hits Phase 3 Milestone

Intellia’s one-time HAE therapy delivers strong results as Cabaletta strikes CAR-T manufacturing deal

  • May 4, 2026

  • 7 min
Bridging the Diabetic Eye Care Divide

Study evaluates eye care utilization of diabetic patients in Northern Uganda, spotlighting limited health literacy and awareness as determining factors in care

  • May 1, 2026

  • 3 min
This Week’s Biopharma News: Wave of Antibody Approvals

FDA expands Tzield, EU clears Dupixent, and Health Canada approves denosumab antibody biosimilars

  • April 28, 2026

  • 5 min